Upload

Loading...

This video is unavailable.

Sorry about that.

Watch Queue

TV Queue

Watch QueueTV Queue

    Loading...

Watch Queue
TV Queue
__count__/__total__
  1. 129

    Periodic fever syndromes

  2. 130

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  3. 131

    A lifelong challenge: periodic fever syndromes

  4. 132

    Connections

  5. 133

    Each Voice Counts - The Women: Part 1

  6. 134

    Each Voice Counts - The Women: Part 2

  7. 135

    Unanswered questions about living with advanced breast cancer

  8. 136

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  9. 137

    Novartis International Biotechnology Leadership Camp 2012

  10. 138

    Journey of Chronic Myeloid Leukemia (CML)

  11. 139

    A look at the past decade in GIST: Chapter 6

  12. 140

    A look at the past decade in GIST: Chapter 5

  13. 141

    A look at the past decade in GIST: Chapter 4

  14. 142

    Vision loss due to Retinal Vein Occlusion (RVO)

  15. 143

    Vision loss due to Diabetic Macular Edema (DME)

  16. 144

    Vision loss due to wet age-related macular degeneration (wet AMD)

  17. 145

    A look at the past decade in GIST: Chapter 3

  18. 146

    Building the next generation of scientists

  19. 147

    A look at the past decade in GIST: Chapter 2

  20. 148

    A look at the past decade in GIST: Chapter 1

  21. 149

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  22. 150

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  23. 151

    Advanced breast cancer 101

  24. 152

    The mTOR pathway in ER+ advanced breast cancer

  25. 153

    Life in a Circle

  26. 154

    Understanding advanced breast cancer

  27. 155

    A Gift for Living

  28. 156

    The Villages Miles Away

  29. 157

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  30. 158

    Could your dog or cat be suffering from an allergy?

  31. 159

    Innovating to help eliminate malaria

  32. 160

    Malaria milestone video message

  33. 161

    Leo and Kya, friends against malaria

  34. 162

    The need for progress: what if?

  35. 163

    The myelofibrosis educational journey

  36. 164

    Understanding the progression of myelofibrosis

  37. 165

    Understanding the management of myelofibrosis

  38. 166

    The myelofibrosis disease burden

  39. 167

    The disease pathway associated with myelofibrosis

  40. 168

    New research developments in myelofibrosis

  41. 169

    Delivery of child-friendly antimalarial hits the 100 million mark

  42. 170

    Treating India's Leprosy patients

  43. 171

    Treating leprosy, caring for patients

  44. 172

    "SMS for Life" is expanding

  45. 173

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  46. 174

    Critical issues facing the advanced breast cancer patient community

  47. 175

    Advice to newly diagnosed advanced breast cancer patients

  48. 176

    Insight into the advanced breast cancer patient journey

  49. 177

    Pioneering an innovative social business model to fight malaria

  50. 178

    New media: drivers of democratization and development?

  51. 179

    What is it like living with myelofibrosis (MF)?

  52. 180

    What is the prognosis of myelofibrosis (MF)?

  53. 181

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  54. 182

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  55. 183

    What is myelofibrosis (MF)?

  56. 184

    How is the patient journey for advanced breast cancer patients different?

  57. 185

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  58. 186

    What is progression free survival and why is it important?

  59. 187

    What guidance do you give patients and family coping with advanced breast cancer?

  60. 188

    What insights can you share with newly diagnosed patients?

  61. 189

    Molecular pathways:The future of research at NIBR

  62. 190

    The importance of organ donation

  63. 191

    Novartis BioCamp 2011 (German)

  64. 192

    Novartis BioCamp 2011 (French)

  65. 193

    How is research in advanced breast cancer evolving?

  66. 194

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  67. 195

    What can a patient expect if diagnosed with advanced breast cancer?

  68. 196

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  69. 197

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  70. 198

    How does the advanced breast cancer treatment journey differ for patients?

  71. 199

    Novartis Be Healthy

  72. 200

    Novartis BioCamp 2011

  73. 201

    A sign from above

  74. 202

    Charlie

  75. 203

    Happy endings

  76. 204

    Herpes #1

  77. 205

    Herpes it's black and white

  78. 206

    Herpes the Ninja virus

  79. 207

    Magical elves with HSV

  80. 208

    Open happiness

  81. 209

    Play it smart

  82. 210

    Quarantine

  83. 211

    Strings

  84. 212

    Ah! Real herpes

  85. 213

    Down there

  86. 214

    Don't let herpes put you off

  87. 215

    Arogya Parivar: A social business model to improve health in rural India

  88. 216

    Living with multiple myeloma

  89. 217

    What are the symptoms of myelofibrosis (MF)?

  90. 218

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  91. 219

    Animals & Research: Think how far we've come

  92. 220

    SMS for Life

  93. 221

    Alcon: helping the world see better

  94. 222

    Cataract Surgery

  95. 223

    Life with cataracts

  96. 224

    CEO Joseph Jimenez on Alcon merger

  97. 225

    Extraordinary dogs: enriching life for disabled veterans

  98. 226

    Improving access to healthcare: too big to solve alone

  99. 227

    Drug discovery and development process

to add this to Watch Later

Add to